Neural Therapeutics Inc.
NURL
CNSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -998.60K | -398.30K | -447.50K | -490.00K | -474.80K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 488.40K | 11.70K | 26.10K | 34.80K | -69.70K |
| Change in Net Operating Assets | 294.50K | 329.60K | 375.70K | 219.90K | 245.60K |
| Cash from Operations | -215.60K | -56.80K | -45.70K | -235.40K | -299.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 11.00K | 11.30K | 11.00K | 11.00K | -- |
| Total Debt Repaid | -12.40K | -- | -- | -- | -- |
| Issuance of Common Stock | 573.50K | 516.40K | 55.00K | 210.20K | 241.20K |
| Repurchase of Common Stock | -- | -- | -95.20K | -95.20K | -95.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -38.50K | 0.00 | 0.00 | -12.60K | -11.90K |
| Cash from Financing | 377.20K | 373.10K | -22.30K | 82.70K | 99.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 161.60K | 316.20K | -68.10K | -152.80K | -199.50K |